Início › Transtorno Depressivo Maior › Arkansas › Little Rock
Ensaios clínicos de Transtorno Depressivo Maior em Little Rock, AR
14 estudos para Transtorno Depressivo Maior estão buscando participantes em locais em Little Rock e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RecrutandoFase 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RecrutandoFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · a 15 mi de distância
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
RecrutandoFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · a 15 mi de distância
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RecrutandoFase 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecrutandoFase 4
- Neurocrine Clinical Site, Bryant · a 15 mi de distância
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RecrutandoFase 3
- SanRo Clinical Research Group, Bryant · a 15 mi de distância
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
RecrutandoFase 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
RecrutandoFase 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecrutandoFase 3
- Neurocrine Clinical Site, Bryant · a 15 mi de distância
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RecrutandoFase 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecrutandoFase 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · a 15 mi de distância
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
RecrutandoFase 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecrutandoFase 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecrutandoFase 3
- Neurocrine Clinical Site, Little Rock
Ensaios de Transtorno Depressivo Maior em outras cidades
- New York City, NY36 estudos
- Boston, MA31 estudos
- Atlanta, GA25 estudos
- Philadelphia, PA23 estudos
- Orlando, FL19 estudos
- Miami, FL18 estudos
- Chicago, IL17 estudos
- Tampa, FL17 estudos
- San Diego, CA16 estudos
- Houston, TX16 estudos
- Austin, TX13 estudos
- Las Vegas, NV13 estudos
Outros estudos em Little Rock
- Esquizofrenia19 estudos
- Câncer (todos os tipos)14 estudos
- Leucemia Mieloide Aguda13 estudos
- Câncer de Pulmão de Não Pequenas Células13 estudos
- Obesidade11 estudos
- Câncer Endometrial10 estudos
- Depressão10 estudos
- Diabetes tipo 210 estudos
- Câncer de Pulmão9 estudos
- Doença Cardiovascular9 estudos
- Câncer de Bexiga9 estudos
- Insuficiência Cardíaca9 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.